Zydus Wellness [ZYDUSWELL] vs Bombay Burmah [BBTC] Detailed Stock Comparison

Zydus Wellness

Bombay Burmah
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Zydus Wellness wins in 9 metrics, Bombay Burmah wins in 11 metrics, with 0 ties. Bombay Burmah appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Zydus Wellness | Bombay Burmah | Better |
---|---|---|---|
P/E Ratio (TTM) | 47.17 | 11.34 | Bombay Burmah |
Price-to-Book Ratio | 2.72 | 2.30 | Bombay Burmah |
Debt-to-Equity Ratio | 3.32 | 20.15 | Zydus Wellness |
PEG Ratio | -3.52 | 1.37 | Zydus Wellness |
EV/EBITDA | 41.44 | 4.49 | Bombay Burmah |
Profit Margin (TTM) | 11.99% | 6.03% | Zydus Wellness |
Operating Margin (TTM) | 16.79% | 14.85% | Zydus Wellness |
EBITDA Margin (TTM) | 16.79% | 14.85% | Zydus Wellness |
Return on Equity | 6.12% | 14.37% | Bombay Burmah |
Return on Assets (TTM) | 5.39% | 8.82% | Bombay Burmah |
Free Cash Flow (TTM) | $3.14B | $19.46B | Bombay Burmah |
Dividend Yield | 0.54% | 0.94% | Bombay Burmah |
1-Year Return | 8.67% | -30.71% | Zydus Wellness |
Price-to-Sales Ratio (TTM) | 5.67 | 0.68 | Bombay Burmah |
Enterprise Value | $155.22B | $150.93B | Zydus Wellness |
EV/Revenue Ratio | 5.69 | 0.80 | Bombay Burmah |
Gross Profit Margin (TTM) | 54.79% | 39.54% | Zydus Wellness |
Revenue per Share (TTM) | $429 | $2,713 | Bombay Burmah |
Earnings per Share (Diluted) | $51.45 | $163.51 | Bombay Burmah |
Beta (Stock Volatility) | -0.23 | 0.54 | Zydus Wellness |
Zydus Wellness vs Bombay Burmah Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Zydus Wellness | 3.04% | 8.64% | 24.42% | 24.09% | 49.23% | 21.93% |
Bombay Burmah | -0.14% | 4.26% | 0.81% | -7.07% | 8.82% | -17.17% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Zydus Wellness | 8.67% | 46.51% | 26.06% | 201.05% | 293.20% | 1,096.76% |
Bombay Burmah | -30.71% | 92.41% | 33.90% | 301.57% | 1,541.69% | 3,232.68% |
News Based Sentiment: Zydus Wellness vs Bombay Burmah
Zydus Wellness
News based Sentiment: POSITIVE
Zydus Wellness has demonstrated strong performance this month with a successful acquisition, positive financial results, and increasing institutional investment. The stock has surged, and analyst ratings remain favorable, indicating a positive trajectory for the company and a strengthening investment case.
Bombay Burmah
News based Sentiment: MIXED
The month presented a mixed picture for Bombay Burmah Trading Corporation, with revenue growth offset by declining profits. However, positive analyst recommendations, a generous dividend, and increasing investor interest provide some counterbalance, making it a moderately significant month for investors.
Performance & Financial Health Analysis: Zydus Wellness vs Bombay Burmah
Metric | ZYDUSWELL | BBTC |
---|---|---|
Market Information | ||
Market Cap | ₹152.94B | ₹129.35B |
Market Cap Category | Mid cap | Mid cap |
10 Day Avg. Volume | 251,572 | 61,392 |
90 Day Avg. Volume | 115,717 | 42,289 |
Last Close | ₹2,473.00 | ₹1,861.60 |
52 Week Range | ₹1,493.20 - ₹2,517.00 | ₹1,607.05 - ₹2,975.00 |
% from 52W High | -1.75% | -37.43% |
All-Time High | ₹2,517.00 (Sep 05, 2025) | ₹2,975.00 (Sep 30, 2024) |
% from All-Time High | -1.75% | -37.43% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.02% | 0.09% |
Quarterly Earnings Growth | -0.13% | 0.08% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.06% |
Operating Margin (TTM) | 0.17% | 0.15% |
Return on Equity (TTM) | 0.06% | 0.14% |
Debt to Equity (MRQ) | 3.32 | 20.15 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹891.31 | ₹807.17 |
Cash per Share (MRQ) | ₹17.16 | ₹228.99 |
Operating Cash Flow (TTM) | ₹2.89B | ₹26.29B |
Levered Free Cash Flow (TTM) | ₹3.47B | ₹11.23B |
Dividends | ||
Last 12-Month Dividend Yield | 0.54% | 0.94% |
Last 12-Month Dividend | ₹11.00 | ₹18.20 |
Valuation & Enterprise Metrics Analysis: Zydus Wellness vs Bombay Burmah
Metric | ZYDUSWELL | BBTC |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 47.17 | 11.34 |
Forward P/E | 30.76 | 4.96 |
PEG Ratio | -3.52 | 1.37 |
Price to Sales (TTM) | 5.67 | 0.68 |
Price to Book (MRQ) | 2.72 | 2.30 |
Market Capitalization | ||
Market Capitalization | ₹152.94B | ₹129.35B |
Enterprise Value | ₹155.22B | ₹150.93B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 5.69 | 0.80 |
Enterprise to EBITDA | 41.44 | 4.49 |
Risk & Other Metrics | ||
Beta | -0.23 | 0.54 |
Book Value per Share (MRQ) | ₹891.31 | ₹807.17 |
Financial Statements Comparison: Zydus Wellness vs Bombay Burmah
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | ZYDUSWELL | BBTC |
---|---|---|
Revenue/Sales | ₹8.58B | ₹46.24B |
Cost of Goods Sold | ₹3.88B | ₹27.96B |
Gross Profit | ₹4.70B | ₹18.28B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹1.45B | ₹6.38B |
EBITDA | ₹1.59B | ₹7.98B |
Pre-Tax Income | ₹1.45B | ₹6.78B |
Income Tax | ₹174.00M | ₹1.80B |
Net Income (Profit) | ₹1.28B | ₹4.98B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | ZYDUSWELL | BBTC |
---|---|---|
Cash & Equivalents | ₹667.00M | ₹3.41B |
Total Current Assets | ₹11.04B | ₹43.46B |
Total Current Liabilities | ₹7.46B | ₹40.49B |
Long-Term Debt | ₹14.00M | ₹7.44B |
Total Shareholders Equity | ₹56.72B | ₹78.13B |
Retained Earnings | ₹20.26B | ₹31.68B |
Property, Plant & Equipment | ₹2.90B | ₹386.05M |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | ZYDUSWELL | BBTC |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | ZYDUSWELL | BBTC |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 251,572 | 61,392 |
Average Daily Volume (90 Day) | 115,717 | 42,289 |
Shares Outstanding | 63.63M | 69.77M |
Float Shares | 18.63M | 15.34M |
% Held by Insiders | 0.70% | 0.78% |
% Held by Institutions | 0.21% | 0.07% |
Dividend Analysis & Yield Comparison: Zydus Wellness vs Bombay Burmah
Metric | ZYDUSWELL | BBTC |
---|---|---|
Last 12-Month Dividend | ₹11.00 | ₹18.20 |
Last 12-Month Dividend Yield | 0.54% | 0.94% |
3-Year Avg Annual Dividend | ₹5.33 | ₹6.87 |
3-Year Avg Dividend Yield | 0.28% | 0.26% |
3-Year Total Dividends | ₹16.00 | ₹20.60 |
Ex-Dividend Date | Jul 11, 2025 | Mar 27, 2025 |